By Dietrich Knauth Aug 20 (Reuters) – Abbott said on Thursday it reached a $670 million settlement to partially resolve the ongoing litigation over alleged harms linked to its specialty formulas for
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)